May 13, 2015 The New York Times: “Cystic Fibrosis Drug Wins Approval of… Read More
May 12, 2015 InsideHealthPolicy.com Health Reform Insider: “As E&C… Read More
May 11, 2015 The Wall Street Journal: “Vertex’s Cystic-Fibrosis… Read More
ICYMI: May 7, 2015 PharmaExec.com: “Take a Breath” on the Specialty Drug… Read More
ICYMI: May 6, 2015 National Journal: Washington’s Interest in Precision… Read More
ICYMI May 5, 2015 The New York Times: Runaway Drug Prices How companies set… Read More
April 28, 2015 Note: Distributing the New York Times article below is not an… Read More
Two-fer ICYMI: Two WSJ Articles Highlight High Drug… Read More
This morning, the National Journal published an article regarding an increase in public concern over the high cost of prescription drugs. The article references CSRxP’s white paper, “Specialty Drug Hyperinflation: The Risk to Patients and the Health Care System.” Read More